Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza, Fernando C
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. [electronic resource] - The New England journal of medicine 07 2019 - 36-46 p. digital
Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa1814427 doi
Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Cyclosporine--adverse effects
Drug Administration Schedule
Female
Glomerulonephritis, Membranous--drug therapy
Humans
Immunologic Factors--therapeutic use
Immunosuppressive Agents--adverse effects
Infusions, Intravenous
Intention to Treat Analysis
Kaplan-Meier Estimate
Male
Middle Aged
Proteinuria--drug therapy
Remission Induction
Rituximab--adverse effects
Treatment Failure
Young Adult
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. [electronic resource] - The New England journal of medicine 07 2019 - 36-46 p. digital
Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa1814427 doi
Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Cyclosporine--adverse effects
Drug Administration Schedule
Female
Glomerulonephritis, Membranous--drug therapy
Humans
Immunologic Factors--therapeutic use
Immunosuppressive Agents--adverse effects
Infusions, Intravenous
Intention to Treat Analysis
Kaplan-Meier Estimate
Male
Middle Aged
Proteinuria--drug therapy
Remission Induction
Rituximab--adverse effects
Treatment Failure
Young Adult